NovoCure Limited Shareholders' Equity
NovoCure Limited (NVCR) had Shareholders' Equity of $338.09 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-23
- 2026-06-30: Stockholders' Equity Attributable to Parent $338.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $330.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $340.47M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $341.33M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $338.09M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $330.72M 10-Q · filed 2026-07-23 |
| 2025-12-31 | $340.47M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $341.33M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $349.44M 10-Q · filed 2026-07-23 |
| 2025-03-31 | $361.96M 10-Q · filed 2026-07-23 |
| 2024-12-31 | $360.18M 10-Q · filed 2026-07-23 |
| 2024-09-30 | $360.78M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $361.75M 10-Q · filed 2025-10-30 |
| 2024-03-31 | $359.36M 10-Q · filed 2025-10-30 |
| 2023-12-31 | $362.50M 10-K · filed 2026-02-26 |
| 2023-09-30 | $393.70M 10-Q · filed 2024-10-30 |
| 2023-06-30 | $415.68M 10-Q · filed 2024-10-30 |
| 2023-03-31 | $432.15M 10-Q · filed 2024-10-30 |
| 2022-12-31 | $441.17M 10-K · filed 2026-02-26 |
| 2022-09-30 | $445.40M 10-Q · filed 2023-10-26 |
| 2022-06-30 | $441.67M 10-Q · filed 2023-10-26 |
| 2022-03-31 | $435.88M 10-Q · filed 2023-10-26 |
| 2021-12-31 | $410.49M 10-K · filed 2025-02-27 |
| 2021-09-30 | $413.16M 10-Q · filed 2022-10-27 |
| 2021-06-30 | $397.27M 10-Q · filed 2022-10-27 |
| 2021-03-31 | $372.13M 10-Q · filed 2022-10-27 |
| 2020-12-31 | $476.53M 10-K · filed 2024-02-22 |
| 2020-09-30 | $307.04M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $267.82M 10-Q · filed 2021-10-28 |
| 2020-03-31 | $241.95M 10-Q · filed 2021-10-28 |
| 2019-12-31 | $217.79M 10-K · filed 2023-02-23 |
| 2019-09-30 | $190.37M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $158.91M 10-Q · filed 2020-10-29 |
| 2019-03-31 | $126.39M 10-Q · filed 2020-10-29 |
| 2018-12-31 | $112.26M 10-K · filed 2022-02-24 |
| 2018-09-30 | $114.94M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $112.08M 10-Q · filed 2019-10-31 |
| 2018-03-31 | $106.12M 10-Q · filed 2019-10-31 |
| 2017-12-31 | $113.56M 10-K · filed 2021-02-25 |
| 2017-09-30 | $116.69M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $117.55M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $128.90M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $142.34M 10-K · filed 2020-02-27 |
| 2016-09-30 | $158.24M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $186.65M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $220.43M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $250.82M 10-K · filed 2019-02-28 |
| 2015-09-30 | $121.22M 10-Q · filed 2015-10-27 |
| 2014-12-31 | $97.88M 10-K · filed 2018-02-22 |
| 2013-12-31 | $171.78M 10-K · filed 2017-02-23 |
| 2012-12-31 | $49.42M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |